MERCAPTOPURINE
HIKMA · MERCAPTOPURINE
Open FDA's page for this record- Application number
- ANDA216418
- Sponsor name
- HIKMA
- Submissions
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20250226
- Review priority
- STANDARD
- Submission class code
- UNKNOWN
- Application docs
- ID
- 81461
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/216418Orig1s000ltr.pdf
- Date
- 20250306
- Type
- Letter
- Products
- Product number
- 001
- Reference drug
- No
- Brand name
- MERCAPTOPURINE
- Reference standard
- No
- Dosage form
- SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Te code
- AB
- Active ingredients
- Name
- MERCAPTOPURINE
- Strength
- 20MG/ML
- Harmonized identifiers (openFDA)
- Application number
- ANDA216418
- Brand name
- MERCAPTOPURINE
- Generic name
- MERCAPTOPURINE
- Manufacturer name
- Hikma Pharmaceuticals USA Inc.
- Product NDC
- 0054-0879, 0054-4582
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- MERCAPTOPURINE
- RxCUI
- 1536484
- SPL ID
- 7490a828-2b59-4972-9a51-fe5173e81aec, 7b9eba74-503d-4704-94e9-d52e8701c7bc
- SPL set ID
- 0a366cf3-91f0-4aa4-8f34-a7a27cad8f15, 25b39be7-fe1e-efe6-e063-6294a90a6e8d
- Package NDC
- 0054-0879-49, 0054-4582-49
- UNII
- E7WED276I5
